Results 61 to 70 of about 26,990 (251)
Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis
Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis. Abstract Background and Aims Nucleotide‐binding oligomerization domain‐like receptor‐family pyrin domain‐containing 3 (NLRP3) inflammasome activation has been shown to result in liver fibrosis.
Jana Knorr +19 more
wiley +1 more source
The search for a myocardial ischemia marker. The case of albumin modified by ischemia
The search for a suitable and reliable marker of myocardial ischemia has led to the proposal of employing the cobalt binding capacity of total serum assuming that ischemic modifications of circulating albumin would markedly decrease its ability to bind ...
Marco Bagnati +3 more
doaj +1 more source
This study confirms that GGT1 is a key driver of neuronal ferroptosis following spinal cord injury. We developed NSCm@EA, a biomimetic delivery system coated with neural stem cell membranes, for precise delivery of enocyanin to injured neurons. By combining targeted delivery with ubiquitination degradation mechanisms, this system promotes MGRN1 ...
Tao Yang +14 more
wiley +1 more source
Is ischemia-modified albumin a reliable tool for the assessment of acute pancreatitis?
Abdurrahman Sahin,1 Semra Turkoglu,2 Nurettin Tunc,1 Deccane Duzenci,3 Ozgen Arslan Solmaz,4 Ibrahim Halil Bahcecioglu,1 Mehmet Yalniz1 1Medicine Faculty, Department of Gastroenterology, Firat University, Elazig, Turkey; 2Department of Nutrition and ...
Sahin A +6 more
doaj
CK2α Deficiency Drives Myocardial Fibrosis via Desmin‐Induced Mitochondrial Dysfunction
CK2α preserves mitochondrial homeostasis by phosphorylating Desmin to recruit Cryab, ensuring proper filament assembly. CK2α deficiency disrupts this interaction, causing mitochondrial dysfunction, metabolic shifts, bioenergetic failure, and oxidative stress—ultimately establishing a pro‐fibrotic environment that drives cardiac fibrosis.
Canjie Ma +12 more
wiley +1 more source
Ischemia-modified albumin in migraine patients during interictal period
Aim. Ischemia-modified albumin (IMA) is a marker of myocardial ischemia and may be affected by ischemia occurring in other tissues. Migraine has been reported as a risk factor of ischemic stroke or cardiovascular events. Dysfunction of endothelial cells,
Slawomir Michalak +8 more
doaj +1 more source
Ischemia-Modified Albumin and Myocardial Ischemia
Sbarouni et al. ([1][1]) reported on “Ischemia-Modified Albumin [IMA] in Relation to Exercise Stress Testing [EST]” in a previous issue of the Journal . Although the investigators found significant differences in the IMA values at baseline, peak exercise, and after EST, there was no ...
Kalay, Nihat +2 more
openaire +1 more source
This study integrates two complementary traditional Chinese medicine components as precursors to synthesize bioactive AM‐AS@CDs. Compared with single‐component CDs, these dual‐component CDs exhibit enhanced antioxidant capacity and superior renoprotective effects.
Bixiao Liu +10 more
wiley +1 more source
Relationship between Ischemia Modified Albumin and Metabolic Syndrome
The aim of the study was to evaluate the association between ischemia modified albumin, inflammation markers, and lipids in patients with metabolic syndrome.
Serap Çuhadar
doaj
Renal IGFBP6 Interacts With THBS1 to Drive Renal Cellular Senescence and Fibrosis
ABSTRACT Epithelial dedifferentiation and myofibroblast activation are critical drivers of chronic kidney disease (CKD) progression. Elevated levels of IGFBP6 have been linked to decreased renal function in CKD patients, but its precise role and underlying mechanisms remain unclear.
Ju‐tao Yu +26 more
wiley +1 more source

